Identification of anxiety sensitivity classes and clinical cut-scores in a sample of adult smokers: Results from a factor mixture model

Allan, Nicholas P.; Raines, Amanda M.; Capron, Daniel W.; Norr, Aaron M.; Zvolensky, Michael J.; Schmidt, Norman B.

doi:10.1016/j.janxdis.2014.07.006

Cited by 77 publications

(62 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The mean ASI-3 score of the sample was 23.6 ( SD = 15.8), indicating a high level of anxiety sensitivity (Allan et al, 2014). There were no differences between men and women in age ( t [255] = −0.81, p = .42), anxiety sensitivity ( t [255] = 1.40, p = .16), or prevalence of past-month nonmedical benzodiazepine use (χ 2 [1] = .22, p = .64).…”

Section: Resultsmentioning

confidence: 99%

Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder

McHugh

Votaw

Bogunovic

et al. 2017

Addictive Behaviors

View full text Add to dashboard Cite

Nonmedical benzodiazepine use is common among adults with opioid use disorder; however, little is known about this co-occurrence. Anxiety sensitivity--the fear of anxiety symptoms and sensations--motivates behaviors to escape and avoid distressing states, and accordingly is associated with coping motives for substance use. This might be particularly relevant among women, who report using substances to cope with negative emotions more often than men. The aim of the current study was to examine whether nonmedical benzodiazepine use was associated with higher anxiety sensitivity among treatment-seeking adults diagnosed with opioid use disorder, and to investigate whether gender moderated this association. A sample of adults (ranging in age from 18–81 years) receiving inpatient treatment for opioid use disorder (N=257) completed measures of anxiety, anxiety sensitivity, and benzodiazepine use frequency. Results of an analysis of variance indicated that frequency of past-month nonmedical benzodiazepine use was associated with significantly higher anxiety sensitivity. This effect remained when controlling for the effect of anxiety symptoms (F[1, 251] = 3.91, p = .049, ηp2=.02). Gender moderated this association, and post-hoc analyses found a strong association between nonmedical benzodiazepine use and anxiety sensitivity in women, and not men. Anxiety sensitivity, which can be reduced with treatment, might be a candidate therapeutic target in this population, particularly in women.

show abstract

Section: Resultsmentioning

confidence: 99%

Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder

McHugh

Votaw

Bogunovic

et al. 2017

Addictive Behaviors

View full text Add to dashboard Cite

show abstract

“…This updated version of the ASI, which we report on in this manuscript, has demonstrated improvements over the original version of the ASI, the ASI-16, including better reliability (Cronbach’s alpha = .89) and factorial validity with correlations between corresponding subscales ranging from .47 to .99 (35). Furthermore, recent research has supported using a cut-off score of 23 to identify high anxiety sensitivity individuals with the ASI-3 (36). …”

Section: Methodsmentioning

confidence: 99%

The Efficacy of Vigorous-Intensity Exercise as an Aid to Smoking Cessation in Adults With High Anxiety Sensitivity

Smits

Zvolensky

Davis

et al. 2016

Psychosomatic Medicine

Self Cite

119

View full text Add to dashboard Cite

Objective High anxiety sensitivity predicts poor smoking cessation outcomes. Aerobic exercise reduces anxiety sensitivity and aspects of the risk conferred by anxiety sensitivity. In the current study, we examined whether exercise can aid smoking cessation in adults with high anxiety sensitivity. Method Participants were sedentary and low activity adult daily smokers (N = 136) with elevated prescreen anxiety sensitivity. Participants received 15 weeks of standard smoking cessation treatment (ST: cognitive behavioral therapy plus nicotine replacement therapy). Additionally, participants were simultaneously randomized to 15 weeks of either an exercise intervention (ST+EX; n = 72) or a wellness education control condition (ST+CTRL; n = 64). Self-reported smoking abstinence was assessed weekly during the intervention, at the end of treatment (10 weeks following the target quit date), and at 4 and 6 months following the target quit date. Abstinence was verified by expired carbon monoxide readings and saliva cotinine. Results Results indicated that point prevalence abstinence (PPA) and prolonged abstinence (PA) rates were significantly higher for ST+EX than for ST+CTRL at each of the major end points among persons with high anxiety sensitivity (PPA: b=−.91, SE=.393, t(1171)=−2.33, p=.020; PA: b=−.98, SE=.346, t(132)=−2.84, p=.005), but not among those with low anxiety sensitivity (PPA: b=−.23, SE=.218, t(1171)=−1.06, p=..29; PA: b=−.31, SE=.306, t(132)=−1.01, p=.32) Conclusions The present results suggest that exercise faciliates the odds of quit success for smokers with high levels of anxiety sensitivity, and therefore, may be a useful therapeutic tactic for this high-risk segment of the smoking population.

show abstract

“…The sample had moderate levels of tobacco dependence according to the FTND ( M = 5.5, SD = 2.01; range = 0–10) and smoked an average of 19.5 ( SD = 8.69) cigarettes per day. The sample averaged moderate levels of anxiety sensitivity on the ASI-3 ( M = 14.4, SD = 13.84; range = 0–58), and 31.8% had ASI-3 scores ≥17, indicating elevated levels of anxiety sensitivity (Allan et al, 2014). Zero-order correlations were examined between study variables (see Table 1).…”

Section: Resultsmentioning

confidence: 99%

“…Time was mean-centered to prevent multicollinearity when using higher-order polynomials (Aiken & West, 1991). Anxiety sensitivity was dichotomized based on a validated clinical cutoff on the ASI-3, with scores < 17 reflecting low levels of anxiety sensitivity and scores ≥17 reflecting moderate or severe levels of anxiety sensitivity (Allan et al, 2014). Participant sex (coded 0 = male, 1 = female) and FTND were entered as model covariates.…”

Section: Methodsmentioning

confidence: 99%

Anxiety sensitivity predicts increased perceived exertion during a 1-mile walk test among treatment-seeking smokers

et al. 2017

View full text Add to dashboard Cite

Smoking increases risk of early morbidity and mortality, and risk is compounded by physical inactivity. Anxiety sensitivity (fear of anxiety-relevant somatic sensations) is a cognitive factor that may amplify the subjective experience of exertion (effort) during exercise, subsequently resulting in lower engagement in physical activity. We examined the effect of anxiety sensitivity on ratings of perceived exertion (RPE) and physiological arousal (heart rate) during a bout of exercise among low-active treatment-seeking smokers. Adult daily smokers (n = 157; Mage = 44.9, SD = 11.13; 69.4% female) completed the Rockport 1.0 mile submaximal treadmill walk test. RPE and heart rate were assessed during the walk test. Multi-level modeling was used to examine the interactive effect of anxiety sensitivity x time on RPE and on heart rate at 5 time points during the walk test. There were significant linear and cubic time x anxiety sensitivity effects for RPE. High anxiety sensitivity was associated with greater initial increases in RPE during the walk test, with stabilized ratings towards the last five minutes, whereas low anxiety sensitivity was associated with lower initial increase in RPE which stabilized more quickly. The linear time x anxiety sensitivity effect for heart rate was not significant. Anxiety sensitivity is associated with increasing RPE during moderate-intensity exercise. Persistently rising RPE observed for smokers with high anxiety sensitivity may contribute to the negative experience of exercise, resulting in early termination of bouts of activity and/or decreased likelihood of future engagement in physical activity.

show abstract

Identification of anxiety sensitivity classes and clinical cut-scores in a sample of adult smokers: Results from a factor mixture model

Cited by 77 publications

References 44 publications

Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder

Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder

The Efficacy of Vigorous-Intensity Exercise as an Aid to Smoking Cessation in Adults With High Anxiety Sensitivity

Anxiety sensitivity predicts increased perceived exertion during a 1-mile walk test among treatment-seeking smokers

Contact Info

Product

Resources

About